AGP Executive Report

Heat & Travel Safety: Europe’s heatwave is already linked to over 1,300 deaths, with France reporting at least 1,000 additional deaths over three days—UK travel warnings cover extreme temperatures in France, Spain and Portugal, but firms aren’t required to cancel just because of heat. Hydration Products in Iceland: Unilever’s Liquid I.V. powdered hydration is expanding into Iceland via Costco, alongside Spain, Germany, France and Sweden—bringing “science-backed” electrolyte mixes to more shoppers. Trade & Health Policy Context: EFTA and Vietnam have concluded a free trade agreement after talks in Reykjavík, covering services, investment, IP, procurement and sustainable development—relevant for how health-related goods and services may move. Air Quality Alert: IQAir’s latest report flags Pakistan as the most polluted country and notes only 13 countries (including Iceland) stayed below the WHO PM2.5 guideline, with wildfires worsening air quality in parts of Europe and the US. Medical Research/Access: SERB Pharmaceuticals completed EU rights acquisition for Idefirix (imlifidase), a conditionally approved transplant medicine, aiming to expand availability across Europe including Iceland. Children’s Rights: Wales joined calls to fully incorporate the UN Convention on the Rights of the Child into law, arguing it improves services and accountability.

Iceland Court Case: Defense asked for Ming Ting Mancel’s acquittal in the Reykjavik Edition trial over the death of her daughter, arguing the prosecution hasn’t proved coercion and challenging how much weight her confession should carry. Trade & Health Policy: EFTA and Vietnam signed a new free trade deal in Reykjavik that also covers sanitary rules—relevant for how medicines and health-related goods move across borders. Air Quality Alert: IQAir’s latest report flags Pakistan as the most polluted country and notes only a small share of cities meet WHO PM2.5 limits; it also lists Iceland among the few countries staying below the threshold. Rare Disease Update: SERB Pharmaceuticals completed EU/UK/Norway/Iceland rights acquisition for Idefirix (imlifidase), tied to transplant access and a required post-authorization study. Wellness on the Move: MSC Cruises rolled out its MSC Aurea Spa with AI skin analysis and medical wellness add-ons like IV therapy and injectables—bringing “wellness tourism” onboard. Hydration Product Push: Liquid I.V. expands across Europe including Iceland, marketing science-backed powdered hydration. Public Health Access: UK medical students abroad (including Iceland via trade agreements) challenge new NHS training prioritisation rules in court.

Ophthalmology Pipeline Update: Oculis will take part in the Piper Sandler Virtual Ophthalmology Conference, highlighting late-stage work including Privosegtor for optic neuritis and Licaminlimab for dry eye disease—both aimed at unmet neuro-ophthalmic and eye-care needs. Rare-Disease Access in Iceland: SERB Pharmaceuticals says it has completed acquisition of EU/UK/NO/CH and Iceland rights to Idefirix (imlifidase), a time-critical transplant medicine, with EU approval conditional on a post-authorization study now fulfilled. Biotech Funding in Reykjavik: Alvotech secured an additional $75m term loan facility (plus earlier equity), bringing access to $240m total to support biosimilar R&D and product launches. Pet Care Warning: The UK’s RSPCA warns pet owners are increasingly using AI chatbots for symptom checks instead of vets, raising safety and legal concerns if animals go untreated. Cross-Border Healthcare Basics: A guide explains how healthcare across European borders works—who can use it, what costs may be covered, and when prior authorisation applies. Whaling & Animal Welfare: Iceland’s renewed commercial whaling is reported alongside claims of animal welfare violations, with campaigners pushing for stronger enforcement and a whaling ban. Nutrition for Everyday Wellness: A dietitian shares a high-fiber, high-protein breakfast formula using oats, Skyr/strained yogurt, and fiber-rich toppings—built for consistency without boredom.

Rare-medicine access in Iceland: SERB Pharmaceuticals says it has completed the acquisition of exclusive EU/UK/Switzerland/Norway/Liechtenstein/Iceland and MENA rights to Idefirix® (imlifidase), aiming to expand availability for patients needing urgent, rare-condition treatment while EMA post-authorization study steps are wrapped up. Health policy & training access: British medical students abroad, including those studying in Iceland via trade-agreement priority rules, have launched a legal challenge in the UK over new NHS training prioritisation laws that they say breach human rights. Bioscience milestone: Neuren Pharmaceuticals’ Rett syndrome drug DAYBU (trofinetide) received a positive CHMP recommendation in Europe, a step toward marketing authorisation that could bring new options for neurobehavioral symptoms. Wellness travel trend: Nordic sauna-and-cold-immersion traditions continue to drive a global wellness travel surge, with Iceland still a key draw for “Viking wellness” style experiences. Public health & pets: UK animal charity RSPCA warns pet owners are increasingly using AI chatbots for symptom advice instead of vets, raising safety concerns.

Rett syndrome breakthrough: Neuren Pharmaceuticals’ partner Acadia won a positive European Medicines Agency CHMP opinion for DAYBU (trofinetide), a potential first EU treatment for neurobehavioral symptoms of Rett syndrome, with a final European Commission decision expected soon—good news for patients and families in Iceland and across Europe. Animal welfare & policy pressure: Iceland’s renewed commercial whaling has restarted despite calls for a ban, with campaigners documenting injuries and alleged violations at sea, keeping the debate on humane treatment and regulation front and center. Cross-border care made clearer: A practical guide explains how cross-border healthcare works in Europe—when you can get treatment abroad, what costs may be covered, and when prior authorisation is needed—helpful for Icelanders planning travel or specialist care. Pet health caution: UK animal charity RSPCA warns pet owners are increasingly using AI chatbots for symptom checks instead of vets, raising concerns about delayed or wrong care. Public health & wellbeing: A dietitian shares a high-fiber, high-protein breakfast formula using oats, skyr/Greek yogurt, and nuts/seeds—an easy, Iceland-relevant nutrition idea for busy mornings.

Courtroom Update (Reykjavik): Prosecutors are seeking up to 16 years for Ming Ting Mancel, the Dublin-based woman on trial in Reykjavik over the murder of her daughter Catherine last June, with the court now weighing whether Catherine could freely choose her fate or was killed against her will. Animal Welfare (Iceland): Iceland’s commercial whaling has resumed after a two-year pause, with reports of two fin whales killed in the renewed hunt and campaigners alleging distress and welfare violations. Public Health (Pets): UK animal charity RSPCA warns that pet owners are increasingly using AI chatbots to diagnose symptoms instead of seeing vets, raising risks of delayed treatment and potential legal trouble. Youth Gambling (Iceland): A new University of Iceland survey finds around 40% of upper secondary students in Iceland gambled in the past year, with researchers linking risk to loneliness and poorer mental wellbeing. Rare Disease (EU/Iceland): Neuren Pharmaceuticals’ Rett syndrome drug DAYBU (trofinetide) has received a positive EU recommendation from CHMP, moving toward a final European Commission decision—potentially the first approved treatment for neurobehavioral symptoms in the EU. Cross-Border Care (Europe): A guide explains how cross-border healthcare works across Europe, including when prior authorisation applies and what costs may be covered.

Kids’ Rights Watch: Kazakhstan surged into the KidsRights Index 2026 top 25, with standout scores in child protection and health—while global pressures like conflict, food insecurity and rising childhood obesity keep threatening children’s wellbeing. Cross-Border Care: A clear explainer on how healthcare rights work across Europe—who can use them, what costs are covered, and when prior authorisation is needed. Rett Syndrome Update: Neuren Pharmaceuticals’ DAYBU (trofinetide) won a positive CHMP opinion for EU marketing authorisation, moving to a European Commission decision and potentially becoming the first EU treatment for Rett neurobehavioral symptoms. Pet Safety Warning: UK animal charity RSPCA says pet owners are increasingly using AI chatbots for symptom checks instead of vets, raising risks of delayed care and even legal trouble. Youth Gambling in Iceland: A University of Iceland survey finds around 40% of upper secondary students gambled in the past year, with loneliness and poorer mental wellbeing linked to higher risk. Water & Health Equity: A global map highlights where safely managed drinking water is still out of reach—showing huge gaps that affect health outcomes. Whale Hunt Returns: Iceland resumed commercial whaling after a pause, with fin whales killed in the opening days, drawing criticism from conservation groups.

Pet Health & Safety: The UK’s animal charity RSPCA warns that pet owners are increasingly using AI chatbots to diagnose symptoms instead of seeing vets, with about 10% of owners turning to AI advice and concerns it could delay proper treatment. Rare Disease Update: Neuren Pharmaceuticals’ Rett syndrome drug DAYBU (trofinetide) has received a positive CHMP opinion in Europe, moving toward a final European Commission decision and potentially becoming the first EU treatment for neurobehavioral symptoms. Youth Gambling in Iceland: A University of Iceland survey finds around 40% of upper secondary students gambled in the past year, with loneliness and poorer mental wellbeing flagged as key risk factors, prompting calls for stronger prevention. Public Health & Access: A new global map highlights where safely managed drinking water is still out of reach, showing major gaps remain despite progress in many wealthy regions. Wellness Culture: Nordic sauna and cold-immersion traditions are driving a global wellness travel surge, as travelers seek “real life” rituals over tech-heavy optimization. Aquatic Community: City centre swimming baths are set to reopen after years of closure, with expanded learn-to-swim and aquatic wellbeing classes planned.

Rett syndrome breakthrough: Iceland-linked patients may benefit as the EU’s CHMP has adopted a positive opinion for Neuren/Acadia’s Daybu (trofinetide), recommending EU marketing authorisation for neurobehavioral symptoms of Rett syndrome in adults and children aged five and up, with a final European Commission decision expected soon. Youth gambling warning in Iceland: A University of Iceland survey finds around 40% of upper secondary students gambled in the past year, with researchers urging stronger prevention, especially as loneliness and poorer mental wellbeing rise. Public health basics mapped: A new global map highlights where safely managed drinking water is still out of reach, underscoring major gaps even as access nears universal levels in many wealthy regions. Whaling returns: After a two-year pause, Iceland has resumed commercial whaling and two fin whales were killed off its coast, drawing criticism from conservation groups. Laundry at lower temps: Guidance says most clothes can be cleaned effectively at 15°C–20°C thanks to modern machines and detergents, cutting energy use without sacrificing cleanliness.

Whale Conservation Clash: Iceland has resumed commercial whaling after a two-year pause, with two fin whales killed in the first days—sparking renewed criticism from animal welfare groups. Public Health Nutrition: A roundup highlights that while salmon is a well-known omega-3 source, some foods like chia seeds and walnuts can provide omega-3s too (with important caveats about conversion). Reykjavík Cost Cuts: A new governing coalition is overhauling Reykjavík City Hall—abolishing offices, cutting 18 positions, and shifting responsibilities to save an estimated ISK 280–330 million a year. Medical Breakthrough in Europe: The EU’s CHMP has issued a positive opinion for DAYBU (trofinetide) for Rett syndrome neurobehavioral symptoms, moving it closer to approval. Dementia Risk Research: A new study points to blood protein GDF15 as an early marker that may predict dementia risk decades later. Water Access Gap: A data-driven map shows safe drinking water is still out of reach for billions, with major gaps even among countries that look “healthy” on paper.

New Dementia Clue: A new blood protein marker, GDF15, may flag dementia risk decades earlier when measured in midlife, offering a potential earlier target for prevention and monitoring. Rett Syndrome Treatment Move: The EU’s CHMP has given a positive opinion for DAYBU (trofinetide) for neurobehavioral symptoms of Rett syndrome in patients aged five and up, with European Commission approval expected next. Cancer Care Update: The EU has approved a perioperative KEYTRUDA plus Padcev regimen for certain bladder cancer patients who can’t receive cisplatin, aiming to cut recurrence and death risk. Reykjavík Cost Cuts: Reykjavík City Hall is restructuring to reduce operating costs, including abolishing offices and cutting staff, with responsibilities shifting across departments. Gender Healthcare Governance: Ireland has set up a Policy and Oversight Group for gender healthcare, citing clinical evidence and learning from services in Iceland and other countries. Kids’ Rights Snapshot: Iceland ranks in the top tier of the KidsRights Index 2026, while Kyrgyzstan and Uzbekistan show mixed results, with healthcare stronger than other child-welfare areas.

Rett syndrome treatment: The EU’s CHMP has issued a positive opinion for Acadia’s DAYBU (trofinetide) to treat neurobehavioral symptoms of Rett syndrome in adults and children aged five and up—if the European Commission follows, it would be the first EU therapy for this specific indication. Cancer care in Europe: The European Commission also approved Merck’s Keytruda plus Padcev for adults with resectable muscle-invasive bladder cancer who can’t receive cisplatin, based on KEYNOTE-905/EV-303 results showing major improvements in event-free survival and pathologic complete response. Dementia risk earlier: A new study points to GDF15, a blood protein measurable in midlife, as an early marker linked to higher dementia risk decades later. Public health prevention: Iceland-developed Planet Youth is being rolled out in Algoma region schools in Canada, aiming to reduce youth alcohol and drug abuse using local risk-factor data. Local health policy: Reykjavík’s new coalition is restructuring City Hall to cut costs, including dissolving the Human Rights Office and shifting related work into other departments.

Rett syndrome treatment in Europe: Acadia’s DAYBU (trofinetide) won a positive CHMP opinion for neurobehavioral symptoms in Rett syndrome for adults and children aged 5+, with European Commission approval still pending—potentially the first EU therapy for this specific need. Cancer care update: The EU also approved KEYTRUDA plus Padcev for cisplatin-ineligible resectable muscle-invasive bladder cancer, adding a new perioperative option for patients across Iceland and the wider EU/EEA. Early dementia risk research: A new study highlights blood protein GDF15 as a potential early marker for dementia risk measured in midlife, pointing to earlier identification and prevention efforts. Local health-adjacent policy: Reykjavík’s new coalition launched a City Hall overhaul to cut operating costs, including dissolving the Communications and Events Office and Human Rights Office, with responsibilities reassigned—an indirect but important shift for community-facing services. Youth substance prevention (Iceland-linked model): Planet Youth, developed in Iceland, is being rolled out in Canada’s Algoma region schools with funding for a five-year contract, aiming to reduce youth alcohol and drug harm using local risk data. Public health rights: UNAIDS leaders warned at the UN about HIV progress being undermined by rights rollbacks and funding withdrawals affecting vulnerable groups.

Dementia Early Warning: A new international study points to blood protein GDF15 as a possible early risk signal for dementia decades before symptoms, measured in midlife (around age 55 or younger). Laundry & Health Habits: New guidance says most clothes can be washed effectively at 15°C thanks to modern machines and detergents, which may help people save energy without sacrificing cleanliness. Reykjavík Cost Cuts: Reykjavík City Hall is restructuring to cut operating costs—abolishing two offices, removing 18 positions, and shifting some work to other departments—aiming to save roughly ISK 280–330 million a year while protecting frontline services. Gender Healthcare Oversight (Ireland): Ireland has set up a Policy and Oversight Group for gender healthcare, with ministers and senior clinicians, and it explicitly references learning from Iceland and other countries. Cancer Treatment Update (EU/Iceland): The EU has approved KEYTRUDA plus Padcev for cisplatin-ineligible muscle-invasive bladder cancer, and Trodelvy for first-line metastatic triple-negative breast cancer in eligible patients. Youth Substance Prevention (Iceland link): Planet Youth, an Iceland-developed prevention model, is being rolled out in Canada’s Algoma region to reduce youth alcohol and drug abuse using local school data.

Cancer Care in Europe: The EU has approved Gilead’s Trodelvy (sacituzumab govitecan) as first-line monotherapy for unresectable or metastatic triple-negative breast cancer in patients not eligible for PD-1/PD-L1 inhibitors, with approval also covering Iceland. Bladder Cancer Update: The European Commission also cleared MSD’s Keytruda (pembrolizumab) plus Padcev (enfortumab vedotin) for adults with resectable muscle-invasive bladder cancer who can’t receive cisplatin, with use across the EU plus Iceland, Norway and Liechtenstein. Youth Substance Abuse Prevention (Iceland-linked): Planet Youth, a prevention model developed in Iceland, is set to roll out in Canada’s Algoma region schools after nearly $600,000 in funding, aiming to reduce early alcohol and drug harm using local grade-10 survey data. Public Health Policy: The Netherlands reported health spending up 6.1% in 2025, while long-term care is rising fastest. Health & Travel Safety: UK airport guidance warns travellers not to bring certain meat and dairy products back from the EU due to animal disease risk, with fines for undeclared items. Global Children’s Rights: Iceland ranks near the top in a new children’s rights index, while Afghanistan is last.

Youth Substance Abuse Prevention: Iceland-developed Planet Youth is being rolled into schools in Canada after nearly $600,000 in funding was secured, aiming to cut youth alcohol and drug misuse by targeting neighbourhood risk factors. Cancer Care in Europe: The European Commission approved Trodelvy as first-line monotherapy for metastatic triple-negative breast cancer in patients not eligible for PD-1/PD-L1 therapy, with Norway and Iceland included. Bladder Cancer Treatment: EC also cleared Keytruda plus Padcev for cisplatin-ineligible muscle-invasive bladder cancer, first as neoadjuvant and then after surgery, with access across EU plus Iceland, Norway and Liechtenstein. Health Funding Cooperation: EU4Health funding access expanded as North Macedonia signed onto the programme, with support for prevention, cancer and cardiovascular care, mental health, and medicines stockpiling. Women’s Sports & Pregnancy Rights: A CAS ruling backed Swedish defender Maja Gothberg after Lazio Women ended her employment due to pregnancy, reinforcing confidentiality and maternity protections. Wellness Research: Sauna use is linked with lower all-cause and cardiovascular death risk in long-term studies, though researchers stress it’s observational. Public Health Watch: A global children’s rights index again placed Afghanistan last, while the Netherlands fell to 22nd, highlighting ongoing gaps in child health and protection.